Aptamer Group reports on significant commercial and technical progress in H1 report

Click:#APTA #RNS #Stocks #AptamerGroup #AptamerSolutions #AptamerDiagnostics #AptamerTherapeutics #Optimer #OptimerBinders #Investing #Unilever #Alzheimers